Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Statistics

Total Valuation

BOM:532531 has a market cap or net worth of INR 86.15 billion. The enterprise value is 102.79 billion.

Market Cap	86.15B
Enterprise Value	102.79B

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Jul 22, 2025

Share Statistics

Current Share Class	92.17M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	7.28%
Owned by Institutions (%)	28.51%
Float	56.70M

Valuation Ratios

The trailing PE ratio is 21.69 and the forward PE ratio is 15.25.

PE Ratio	21.69
Forward PE	15.25
PS Ratio	1.84
PB Ratio	3.07
P/TBV Ratio	5.71
P/FCF Ratio	21.60
P/OCF Ratio	12.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.21, with an EV/FCF ratio of 25.77.

EV / Earnings	25.87
EV / Sales	2.20
EV / EBITDA	12.21
EV / EBIT	15.15
EV / FCF	25.77

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.66.

Current Ratio	1.15
Quick Ratio	0.47
Debt / Equity	0.66
Debt / EBITDA	2.20
Debt / FCF	4.62
Interest Coverage	4.37

Financial Efficiency

Return on equity (ROE) is 16.45% and return on invested capital (ROIC) is 9.21%.

Return on Equity (ROE)	16.45%
Return on Assets (ROA)	6.75%
Return on Invested Capital (ROIC)	9.21%
Return on Capital Employed (ROCE)	18.60%
Revenue Per Employee	14.18M
Profits Per Employee	1.20M
Employee Count	3,301
Asset Turnover	0.75
Inventory Turnover	1.56

Taxes

In the past 12 months, BOM:532531 has paid 826.07 million in taxes.

Income Tax	826.07M
Effective Tax Rate	16.68%

Stock Price Statistics

The stock price has decreased by -46.63% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.63%
50-Day Moving Average	852.44
200-Day Moving Average	761.68
Relative Strength Index (RSI)	71.54
Average Volume (20 Days)	49,588

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:532531 had revenue of INR 46.79 billion and earned 3.97 billion in profits. Earnings per share was 43.12.

Revenue	46.79B
Gross Profit	25.92B
Operating Income	6.75B
Pretax Income	4.95B
Net Income	3.97B
EBITDA	8.38B
EBIT	6.75B
Earnings Per Share (EPS)	43.12

Balance Sheet

The company has 2.27 billion in cash and 18.44 billion in debt, giving a net cash position of -16.16 billion.

Cash & Cash Equivalents	2.27B
Total Debt	18.44B
Net Cash	-16.16B
Net Cash Per Share	n/a
Equity (Book Value)	28.03B
Book Value Per Share	299.06
Working Capital	4.23B

Cash Flow

In the last 12 months, operating cash flow was 6.96 billion and capital expenditures -2.97 billion, giving a free cash flow of 3.99 billion.

Operating Cash Flow	6.96B
Capital Expenditures	-2.97B
Free Cash Flow	3.99B
FCF Per Share	n/a

Margins

Gross margin is 55.40%, with operating and profit margins of 14.43% and 8.49%.

Gross Margin	55.40%
Operating Margin	14.43%
Pretax Margin	10.59%
Profit Margin	8.49%
EBITDA Margin	17.92%
EBIT Margin	14.43%
FCF Margin	8.53%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.49%.

Dividend Per Share	4.00
Dividend Yield	0.49%
Dividend Growth (YoY)	60.00%
Years of Dividend Growth	1
Payout Ratio	9.28%
Buyback Yield	-0.28%
Shareholder Yield	0.21%
Earnings Yield	4.61%
FCF Yield	4.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7